Assessment of tolerability in elderly patients: Changing to lamotrigine therapy

American Journal Geriatric Pharmacotherapy

Volumn 5, Issue 2, 2007, Pages 112-119

  Evans, Bradley K ^a   Kustra, Robert P ^b   Hammer, Anne E ^b  

^a Northern Michigan Neurology   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

antiepileptic drug; epilepsy; lamotrigine; monotherapy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; EPILEPSY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROFILE OF MOOD STATES; QUALITY OF LIFE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT;

AFFECT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; TRIAZINES;

EID: 34547949534     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2007.06.001     Document Type: Article

References (16)

1. Hauser W. Seizure disorders: The changes with age. Epilepsia 33 Suppl 4 (1992) S6-S14
2. Hauser W., Annegers J., and Kurland L. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935-1984. Epilepsia 34 (1993) 453-468
3. Tallis R., Hall G., Craig I., and Dean A. How common are epileptic seizures in old age?. Age Ageing 20 (1991) 442-448
4. for the UK Lamotrigine Elderly Study Group. Brodie M., Overstall P., and Giorgi L. Multicentre, doubleblind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 37 (1999) 81-87
5. for the VA Cooperative Study 428 Group. Rowan A., Ramsay R., Collins J., et al. New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, carbamazepine. Neurology 64 (2005) 1868-1873
6. Willmore L. Antiepileptic drug therapy in the elderly. Pharmacol Ther 78 (1998) 9-16
7. for the TARGET Study Group. Kustra R., Meador K., Evans B., et al. Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen. Seizure 14 (2005) 254-261
8. Baker G., Jacoby A., Buck D., et al. Quality of life of people with epilepsy: A European study. Epilepsia 38 (1997) 353-362
9. Gilliam F., Fessler A., Baker G., et al. Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial. Neurology 62 (2004) 23-27
10. Cramer J., Perrine K., Devinsky O., et al. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 39 (1998) 81-88
11. McNair D., Lorr M., and Droppleman L. EITS Manual for the Profile of Mood States (1971), Educational and Industrial Testing Service, San Diego, Calif
12. Lamictal [package insert] (2006), Glaxo Smith Kline, Research Triangle Park, NC
13. Cramer J., Hammer A., and Kustra R. Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy Behav 5 (2004) 224-230
14. O'Mahony M., and Woodhouse K. Age, environmental factors and drug metabolism. Pharmacol Ther 61 (1994) 279-287
15. Bressler R., and Bahl J. Principles of drug therapy for the elderly patient. Mayo Clin Proc. 78 (2003) 1564-1577
16. Kalogjera-Sackellares D., and Sackellares J. Improvement in depression associated with partial epilepsy in patients treated with lamotrigine. Epilepsy Behav 3 (2002) 510-516